Follistatin 344

Follistatin is a naturally occurring binding protein that regulates several members of the transforming growth factor-beta, or TGF-β, superfamily. Two of its best-known targets are activin A and myostatin (GDF-8). Myostatin acts as an important negative regulator of skeletal-muscle growth, while activin participates in reproductive, metabolic, inflammatory, and tissue-regulatory pathways. By binding these signaling proteins before they reach their receptors, follistatin can reduce downstream signaling activity.

The term Follistatin 344, or FS344, refers to the 344-amino-acid precursor that is processed to produce the longer circulating FS315 isoform. This longer form differs from the shorter FS288 isoform in its tissue distribution and binding characteristics. That distinction matters because many commercial descriptions incorrectly treat “Follistatin 344” as though it were simply a 344-amino-acid injectable peptide with a single straightforward muscle-building mechanism. In reality, follistatin biology involves several ligands and multiple regulatory systems.

Much of the interest in Follistatin 344 comes from animal studies and gene-transfer experiments showing increased skeletal-muscle mass after suppression of myostatin signaling. Human FS344 research has also been performed, but the best-known studies delivered the FS344 gene through an adeno-associated viral vector, causing muscle cells to produce follistatin themselves. That is biologically and pharmacologically different from administering recombinant Follistatin 344 protein directly.